On August 5, 2014 we introduced that the field of personalized medicine has grown rapidly and has encompassed both the field of genetic testing and mobile health apps.  Today we take a closer look at direct-to-consumer genetic testing.  It took thirteen years for the first draft of the human genome to be completed.  In the eleven years since this monumental accomplishment the field of genomics has grown exponentially.  And the fruits of this growth are multi-faceted: tests for disease association, risk, diagnosis, treatment; the list goes on and on.  However the implications for the results of these tests are far-reaching and have a direct affect on both the individual person and on the greater collective.  In the wake of this rapid development of genomic knowledge and increasingly more powerful computers and equipment capable of processing this information, many companies have formed to provide direct to consumer, relatively low cost personalized genomic information.  And with the creation of these companies, the FDA has taken a closer look at the information being disseminated to the consumer.